Heart rate variability in beta-thalassemia patients

European Journal of Haematology

Volumn 83, Issue 5, 2009, Pages 483-489

  Rutjanaprom, Wasarut ^a,b   Kanlop, Natnicha ^a,b   Charoenkwan, Pimlak ^b   Sittiwangkul, Rekwan ^b   Srichairatanakool, Somdet ^b   Tantiworawit, Adisak ^b   Phrommintikul, Arintaya ^b   Chattipakorn, Siriporn ^b   Fucharoen, Suthat ^c   Chattipakorn, Nipon ^a,b  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b Faculty of Medicine Chiang Mai University   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Anemia; Heart rate variability; Thalassemia major

Indexed keywords

DEFEROXAMINE; FERRITIN; HEMOGLOBIN; IRON; NON TRANSFERRIN BOUND IRON; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHELATION THERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEART RATE VARIABILITY; HEMATOCRIT; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; MALE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CHILD; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HEMOGLOBINS; HUMANS; IRON; MALE; MYOCARDIAL INFARCTION; REACTIVE OXYGEN SPECIES;

EID: 70349952482     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01314.x     Document Type: Article

References (44)

1. Engle MA. Cardiac involvement in Cooley's anemia. Ann N Y Acad Sci 1964 119 : 694 702.
2. Olivieri NF, Nathan DG, MacMillan JH, Wayne AS, Liu PP, McGee A, Martin M, Koren G, Cohen AR. Survival in medically treated patients with homozygous beta-thalassemia. N Engl J Med 1994 331 : 574 578.
3. Zurlo MG, De Stefano P, Borgna-Pignatti C, Di Palma A, Piga A, Melevendi C, DiGredorio F, Burattini MG, Terzoli S. Survival and causes of death in thalassaemia major. Lancet 1989 2 : 27 30.
4. Olivieri NF. The beta-thalassemias. N Engl J Med 1999 341 : 99 109.
5. Borgna-Pignatti C, Rugolotto S, De SP, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 2004 89 : 1187 1193.
6. Hoffbrand AV, Cohen A, Hershko C. Role of deferiprone in chelation therapy for transfusional iron overload. Blood 2003 102 : 17 24.
7. Fitchett DH, Coltart DJ, Littler WA, Leyland MJ, Trueman T, Gozzard DI, Peters TJ. Cardiac involvement in secondary haemochromatosis: a catheter biopsy study and analysis of myocardium. Cardiovasc Res 1980 14 : 719 724.
8. Lee DH, Jacobs DR Jr. Serum markers of stored body iron are not appropriate markers of health effects of iron: a focus on serum ferritin. Med Hypotheses 2004 62 : 442 445.
9. Hoffbrand AV. Diagnosing myocardial iron overload. Eur Heart J 2001 22 : 2140 2141.
10. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001 22 : 2171 2179.
11. Breuer W, Ermers MJ, Pootrakul P, Abramov A, Hershko C, Cabantchik ZI. Desferrioxamine-chelatable iron, a component of serum non-transferrin-bound iron, used for assessing chelation therapy. Blood 2001 97 : 792 798.
12. Hershko C, Link G, Cabantchik I. Pathophysiology of iron overload. Ann N Y Acad Sci 1998 850 : 191 201.
13. Grosse R, Lund U, Caruso V, Fischer R, Janka GE, Magnano C, Engelhardt R, Durken M, Nielsen P. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major. Ann N Y Acad Sci 2005 1054 : 429 432.
14. Jakeman A, Thompson T, McHattie J, Lehotay DC. Sensitive method for nontransferrin-bound iron quantification by graphite furnace atomic absorption spectrometry. Clin Biochem 2001 34 : 43 7.
15. La Rovere MT, Pinna GD, Hohnloser SH, Marcus FI, Mortara A, Nohara R, Bigger JT Jr., Camm AJ, Schwartz PJ. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation 2001 103 : 2072 2077.
16. Nolan J, Batin PD, Andrews R, et al. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation 1998 98 : 1510 1516.
17. De Chiara B, Crivellaro W, Sara R, Ruffini L, Parolini M, Fesslova V, Carnelli V, Fiorentini C, Parodi O. Early detection of cardiac dysfunction in thalassemic patients by radionuclide angiography and heart rate variability analysis. Eur J Haematol 2005 74 : 517 522.
18. Franzoni F, Galetta F, Di Muro C, Buti G, Pentimone F, Santoro G. Heart rate variability and ventricular late potentials in beta-thalassemia major. Haematologica 2004 89 : 233 234.
19. Gurses D, Ulger Z, Levent E, Aydinok Y, Ozyurek AR. Time domain heart rate variability analysis in patients with thalassaemia major. Acta Cardiol 2005 60 : 477 481.
20. Veglio F, Melchio R, Rabbia F, Molino P, Genova GC, Martini G, Schiavone D, Piga A, Chiandussi L. Blood pressure and heart rate in young thalassemia major patients. Am J Hypertens 1998 11 : 539 547.
21. Singh S, Hider RC, Porter JB. A direct method for quantification of non-transferrin-bound iron. Anal Biochem 1990 186 : 320 323.
22. Amer J, Goldfarb A, Fibach E. Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol 2003 70 : 84 90.
23. Bigger JT Jr., Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation 1992 85 : 164 171.
24. Vaishnav S, Stevenson R, Marchant B, Lagi K, Ranjadayalan K, Timmis AD. Relation between heart rate variability early after acute myocardial infarction and long-term mortality. Am J Cardiol 1994 73 : 653 657.
25. Copie X, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol 1996 27 : 270 276.
26. Cripps TR, Malik M, Farrell TG, Camm AJ. Prognostic value of reduced heart rate variability after myocardial infarction: clinical evaluation of a new analysis method. Br Heart J 1991 65 : 14 9.
27. Mortara A, La Rovere MT, Signorini MG, Pantaleo P, Pinna G, Martinelli L, Ceconi C, Cerutti S, Tavazzi L. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation Br Heart J 1994 71 : 422 430.
28. Casolo G, Balli E, Taddei T, Amuhasi J, Gori C. Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol 1989 64 : 1162 1167.
29. Kleiger RE, Miller JP, Bigger JT Jr., Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol 1987 59 : 256 262.
30. Malik M, Camm AJ, Janse MJ, Julian DG, Frangin GA, Schwartz PJ. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol 2000 35 : 1263 1275.
31. Zuanetti G, Neilson JM, Latini R, Santoro E, Maggioni AP, Ewing DJ. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. Circulation 1996 94 : 432 436.
32. Akyol A, Alper AT, Cakmak N, Hasdemir H, Eksik A, Oguz E, Erdinler I, Ulufer FT, Gurkan K. Long-term effects of cardiac resynchronization therapy on heart rate and heart rate variability. Tohoku J Exp Med 2006 209 : 337 346.
33. Gilliam FR III., Singh JP, Mullin CM, McGuire M, Chase KJ. Prognostic value of heart rate variability footprint and standard deviation of average 5-minute intrinsic R-R intervals for mortality in cardiac resynchronization therapy patients. J Electrocardiol 2007 40 : 336 342.
34. Gilliam FR III., Kaplan AJ, Black J, Chase KJ, Mullin CM. Changes in heart rate variability, quality of life, and activity in cardiac resynchronization therapy patients: results of the HF-HRV registry. Pacing Clin Electrophysiol 2007 30 : 56 64.
35. Piepoli MF, Villani GQ, Corra U, Aschieri D, Rusticali G. Time course of effects of cardiac resynchronization therapy in chronic heart failure: benefits in patients with preserved exercise capacity. Pacing Clin Electrophysiol 2008 31 : 701 708.
36. Puglisi A, Gasparini M, Lunati M, et al. Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients. J Cardiovasc Electrophysiol 2008 19 : 693 701.
37. Saul JP, Arai Y, Berger RD, Lilly LS, Colucci WS, Cohen RJ. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 1988 61 : 1292 1299.
38. Dalla PR, Fuchs A, Bechtold S, Kozlik-Feldmann R, Daebritz S, Netz H. Short-term testing of heart rate variability in heart-transplanted children: equal to 24-h ECG recordings? Clin Transplant 2006 20 : 438 442.
39. Pozza RD, Kleinmann A, Bechtold S, Fuchs A, Netz H. Reinnervation after heart transplantation in children: results of short-time heart rate variability testing. Pediatr Transplant 2006 10 : 429 433. (Pubitemid 43780675)
40. Havlicekova Z, Jurko A Jr. Heart rate variability changes in children after cardiac transplantation. Bratisl Lek Listy 2005 106 : 168 170.
41. Bellavere F, Balzani I, De Masi G, Carraro M, Carenza P, Cobelli C, Thomaseth K. Power spectral analysis of heart-rate variations improves assessment of diabetic cardiac autonomic neuropathy. Diabetes 1992 41 : 633 640.
42. Becker K, Gorlach I, Frieling T, Haussinger D. Characterization and natural course of cardiac autonomic nervous dysfunction in HIV-infected patients. AIDS 1997 11 : 751 757.
43. Romero Mestre JC, Hernandez A, Agramonte O, Hernandez P. Cardiovascular autonomic dysfunction in sickle cell anemia: a possible risk factor for sudden death? Clin Auton Res 1997 7 : 121 125.
44. Sozen AB, Demirel S, Akkaya V, Kudat H, Tukek T, Yeneral M, Ozcan M, Guven O, Korkut F. Autonomic dysfunction in vitamin B12 deficiency: a heart rate variability study. J Auton Nerv Syst 1998 71 : 25 7.